Cargando…
Evaluating the diagnostic and prognostic value of serum TuM2‐PK, NSE, and ProGRP in small cell lung cancer
BACKGROUND: The aim of this study was to explore the diagnostic and prognostic value of serum tumor M2‐pyruvate kinase (TuM2‐PK), neuron‐specific enolase (NSE), and progastrin‐releasing peptide (ProGRP) levels in patients with small cell lung cancer (SCLC). METHODS: The levels of serum TuM2‐PK, NSE,...
Autores principales: | Li, Li, Zhang, Qian, Wang, Yuchao, Xu, Chunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220296/ https://www.ncbi.nlm.nih.gov/pubmed/37088873 http://dx.doi.org/10.1002/jcla.24865 |
Ejemplares similares
-
ProGRP与NSE对小细胞肺癌诊断价值的meta分析
Publicado: (2010) -
血清NSE、ProGRP和LDH在小细胞肺癌诊断治疗中的作用
Publicado: (2016) -
Utility of the Serum ProGRP Level for Follow-up of Pulmonary Carcinoid Tumors
por: Taira, Naohiro, et al.
Publicado: (2014) -
Evaluation of chemiluminescent immunoassay quantitative detection for pro-gastrin-releasing peptide (ProGRP) in serum and plasma
por: Cheng, Yizhuang, et al.
Publicado: (2019) -
Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report
por: Oya, Yuko, et al.
Publicado: (2018)